2.06
-13.45%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About DarioHealth
From its filings with the US Securities and Exchange Commission
DarioHealth is based in New York, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker DRIO. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $22.4m and a net loss of $41.7m. At that date it held total assets of $110.1m and shareholders' equity of $67.9m.
We are a vertically integrated health intelligence platform with a mission to power the behavior changes that drive better health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, AI built on that proprietary data, and a behavior change and coaching layer validated through over 100 peer-reviewed clinical studies. We are committed to transforming healthcare by delivering a comprehensive and highly engaging whole-person health platform, which enables us to create a future where healthy change is effortless and accessible to all.
At the core of our mission and vision is engagement. We believe that most existing digital health solutions in the market fail to deliver improved health outcomes because users are not engaged due to a lack relevance, personalization, consumerization, and longitudinal data and information. We, and our acquired companies, first commercialized our digital behavioral health products in the direct-to-consumer (“D2C”) marketplace, and we continue to use the D2C marketplace as a sandbox and laboratory to innovation. These consumers pay for these digital health products out of their own pockets and are therefore the most value driven among all healthcare consumers. These consumers demanded that we deliver highly engaging user experiences that deliver strong clinical health outcomes for which consumers will pay.
Quoted from its 10-K, filed 19 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Mar 2013
- Employees
- 160
- Website
- mydario.com ↗
- Head office
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Yoav ShakedIndependent Chairman of the Board$168,700
- Mr. Steven NelsonPresident, Chief Commercial Officer$789,372
- Mr. Erez RaphaelChief Executive Officer, Director, since 2013$2.0m
- Mrs. Chen Franco-YehudaChief Financial Officer, Treasurer, Secretary
- Mr. Lawrence LeisureDirector
- Mr. Adam SternDirector$130,100
- Ms. Hila KarahIndependent Director$135,100
- Mr. Dennis MatheisIndependent Director$135,100
- Mr. Dennis McgrathIndependent Director$204,400
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 23
- Environment
- 25
- Social
- 26
- Governance
- 18
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- DarioHealth Corp employs 160 employees in New York City for digital therapeutics development.
- DarioHealth operates at the intersection of life sciences and software technology for integrated solutions.
- DarioHealth's products are available via Amazon, Walmart, Best Buy, and app stores for direct consumer access.
Weaknesses
- DarioHealth has 62 full-time employees as of the latest report.
- DarioHealth's IPO was on 8 March 2013, which may indicate limited market history.
- DarioHealth's business description mentions a lack of detailed financial data.
Opportunities
- DarioHealth can expand its digital therapeutics offerings in the Health Care sector.
- DarioHealth can leverage partnerships with Amazon, Walmart, and Best Buy for wider market reach.
- DarioHealth can enhance its DarioEngage platform for real-time caregiver connectivity.
Threats
- DarioHealth faces competition in the Health Care digital therapeutics market.
- DarioHealth's reliance on app stores may lead to platform dependency risks.
- DarioHealth's products are limited to specific health conditions like diabetes management.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.